Foundation Medicine portal adds navify® Clinical Hub tools
News | Oncology | August 4, 2026
AI-powered patient education, clinical trial match, publication search and guidelines tools in navify Clinical Hub are now integrated with the Foundation Medicine portal to empower clinical decision-making.
Seamlessly integrating genomic insights into clinical workflows
By ingesting discrete, structured data directly from Foundation Medicine comprehensive genomic profiling (CGP) reports, navify Clinical Hub provides care teams with real-time access to clinical decision making support aligned with biomarker testing results. This includes AI-powered patient education, clinical trial matching, publication search and guideline tools – that can streamline workflows, reduce administrative burdens and empower more informed treatment decisions.¹
AI-powered patient education
Translate complex genomic results into easily understandable aids for patients and caregivers. AI‑driven summaries can help simplify discussions and support patients in staying informed throughout their care journey.
Precise clinical decision support
Foundation Medicine CGP reports help treatment decision making for patients. Healthcare professionals can personalize treatment using navify Clinical Hub clinical decision support tools that filter based on patient-specific characteristics – such as cancer type and biomarkers – to deliver highly targeted care.
These newly integrated tools will grant care teams with quick, simplified access to resources that will enable them to maximize the impact of the short time they have with their patients.
About Foundation Medicine
Foundation Medicine is a global, patient-focused precision medicine company delivering high-quality, transformative diagnostic solutions in cancer and other diseases. We provide tests and solutions to transform care throughout a patient’s experience, from defining a diagnosis to determining the appropriate treatment to ongoing monitoring. We help accelerate the development of new personalized therapies by leveraging our vast knowledge of precision medicine, real world data and AI-powered tools, expanding the information our diagnostic solutions provide to enable improved outcomes for patients. Every day, we are inspired to think differently to transform the lives of people living with cancer and other diseases.
References and notes
Hoffman-La Roche. Qualitative evaluation of navify® Clinical Hub for Oncology in Veterans General Hospital Taipei. Basel: Hoffman-La Roche; 2026. Report No.: MC--19956.
Disclaimer
Not every digital product is available in all markets. The use of any third-party app is subject to a separate license agreement with the respective third-party app developer. Roche gives no warranties (express or implied) with regard to any third-party app. Third-party apps might not be available in your country. This website and its content may be accessible worldwide, Roche assumes no liability with regard to the access to the information, which may not be compatible with legislations or regulations in force in your country.
navify® Clinical Hub and Foundation Medicine integration